98%
921
2 minutes
20
Although the application of artificial intelligence in orthopedics is becoming increasingly widespread, and initial progress has been made particularly in total hip arthroplasty (THA), its use in preoperative planning remains in the exploratory stage. Most existing studies are small-scale observational studies with inconsistent results, making it difficult to establish a unified clinical consensus. Therefore, our study aims to explore the latest research developments and potential unique advantages of artificial intelligence in preoperative planning for THA. We conducted a comprehensive literature search in PubMed, Embase, Web of Science, and the Cochrane Library, covering all publications up to April 23, 2025. To evaluate study quality, we applied the revised Cochrane Risk of Bias tool for randomized controlled trials and the Newcastle-Ottawa Scale (NOS) for non-randomized studies. For the statistical analysis, odds ratios (OR) were used to assess categorical variables, while mean differences (MD) were calculated for continuous outcomes. Depending on the level of heterogeneity, a random-effects model was adopted when substantial heterogeneity was detected (I > 50%); otherwise, a fixed-effects model was applied. Through this process, a total of 518 studies were initially identified, of which 16 met the predefined inclusion criteria. The pooled analysis demonstrated that, in comparison to traditional methods, artificial intelligence achieved significantly superior outcomes in several key areas: acetabular-side matching accuracy (OR = 0.24), femoral-side matching accuracy (OR = 0.24), postoperative leg length discrepancy (MD = -1.02), operative time (MD = -12.18 min), intraoperative blood loss (MD = -50.82 mL), and postoperative Harris hip score (MD = 1.42). Notably, the overall methodological quality of the included studies was generally high. The final results of the study indicate that, compared to traditional preoperative planning, artificial intelligence in preoperative planning for THA can provide more precise surgical guidance, reduce surgical risks, and improve the overall success rate of the procedure. Trial Registration: PROSPERO registration number: CRD42024619714.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/os.70156 | DOI Listing |
JMIR Hum Factors
September 2025
Seidenberg School of Computer Science and Information Systems, Pace University, New York City, NY, United States.
Background: As information and communication technologies and artificial intelligence (AI) become deeply integrated into daily life, the focus on users' digital well-being has grown across academic and industrial fields. However, fragmented perspectives and approaches to digital well-being in AI-powered systems hinder a holistic understanding, leaving researchers and practitioners struggling to design truly human-centered AI systems.
Objective: This paper aims to address the fragmentation by synthesizing diverse perspectives and approaches to digital well-being through a systematic literature review.
J Med Microbiol
September 2025
Alberta Precision Laboratories Public Health Lab, Edmonton, Alberta, Canada.
For thousands of years, parasitic infections have represented a constant challenge to human health. Despite constant progress in science and medicine, the challenge has remained mostly unchanged over the years, partly due to the vast complexity of the host-parasite-environment relationships. Over the last century, our approaches to these challenges have evolved through considerable advances in science and technology, offering new and better solutions.
View Article and Find Full Text PDFInt J Surg
September 2025
Department of Oral and Maxillofacial Surgery, The Affiliated Tai'an City Central Hospital of Qingdao University, Taian, China.
J Robot Surg
September 2025
Department of CSE, United Institute of Technology, Coimbatore, India.
Diabetologia
September 2025
Department of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
This review article, developed by the EASD Global Council, addresses the growing global challenges in diabetes research and care, highlighting the rising prevalence of diabetes, the increasing complexity of its management and the need for a coordinated international response. With regard to research, disparities in funding and infrastructure between high-income countries and low- and middle-income countries (LMICs) are discussed. The under-representation of LMIC populations in clinical trials, challenges in conducting large-scale research projects, and the ethical and legal complexities of artificial intelligence integration are also considered as specific issues.
View Article and Find Full Text PDF